In appropriate neurochemical, functional, and behavioural non-clinical experiments, escitalopram shows greater efficacy
and faster onset of action than comparable doses of
citalopram. The lower efficacy of
citalopram in these studies is apparently due to the inhibition of the effect of the S-enantiomer by the R-enantiomer, possibly via an allosteric interaction with the serotonin transporter.